Sunil Babu

机构：Fort Wayne Medical Institute · ORCID：0000-0001-5085-6905

发表论文 105 篇 · 总被引 8656 次 · h-index 28

代表论文

• Genetic risk stratification and outcomes among treatment-naive patients with AML treated with venetoclax and azacitidine (2024 · Blood · 被引 146)
• Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage SCLC: Results From TROPiCS-03 (2025 · Journal of Thoracic Oncology · 被引 51)
• Mosunetuzumab and Polatuzumab Vedotin Demonstrates Preliminary Efficacy in Elderly Unfit/Frail Patients with Previously Untreated Diffuse Large B-Cell Lymphoma (2023 · Blood · 被引 24)
• Safety and efficacy of ABBV-706, a seizure-related homolog protein 6 (SEZ6)–targeting antibody-drug conjugate, in high-grade neuroendocrine neoplasms. (2025 · Journal of Clinical Oncology · 被引 9)
• ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera (2025 · Acta Haematologica · 被引 7)
• Optimizing Clinical Trial Subject Selection: Insights from Exigent Research Network and the Tempus AI TIME Program Collaboration (2024 · AI in Precision Oncology · 被引 6)